K
Kiora Pharmaceuticals, Inc.
Profile managed by Bizz IdKiora Pharmaceuticals
Estados Unidos
11-50 employees
2013
Description
Clinical-stage biopharmaceutical company founded in 2013 in Encinitas, California. Listed on NASDAQ (KPRX). Develops advanced treatments for retinal diseases including retinitis pigmentosa and AMD, with candidate KIO-301 (molecular photoswitch) in Phase 2.